These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

560 related articles for article (PubMed ID: 7533609)

  • 1. Gene therapy for the respiratory manifestations of cystic fibrosis.
    Korst RJ; McElvaney NG; Chu CS; Rosenfeld MA; Mastrangeli A; Hay J; Brody SL; Eissa NT; Danel C; Jaffe HA
    Am J Respir Crit Care Med; 1995 Mar; 151(3 Pt 2):S75-87. PubMed ID: 7533609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene transfer to freshly isolated human respiratory epithelial cells in vitro using a replication-deficient adenovirus containing the human cystic fibrosis transmembrane conductance regulator cDNA.
    Rosenfeld MA; Chu CS; Seth P; Danel C; Banks T; Yoneyama K; Yoshimura K; Crystal RG
    Hum Gene Ther; 1994 Mar; 5(3):331-42. PubMed ID: 7517189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy for cystic fibrosis using E1-deleted adenovirus: a phase I trial in the nasal cavity. The University of North Carolina at Chapel Hill.
    Boucher RC; Knowles MR; Johnson LG; Olsen JC; Pickles R; Wilson JM; Engelhardt J; Yang Y; Grossman M
    Hum Gene Ther; 1994 May; 5(5):615-39. PubMed ID: 7519885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modification of nasal epithelial potential differences of individuals with cystic fibrosis consequent to local administration of a normal CFTR cDNA adenovirus gene transfer vector.
    Hay JG; McElvaney NG; Herena J; Crystal RG
    Hum Gene Ther; 1995 Nov; 6(11):1487-96. PubMed ID: 8573621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis.
    Crystal RG; McElvaney NG; Rosenfeld MA; Chu CS; Mastrangeli A; Hay JG; Brody SL; Jaffe HA; Eissa NT; Danel C
    Nat Genet; 1994 Sep; 8(1):42-51. PubMed ID: 7527271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute responses of non-human primates to airway delivery of an adenovirus vector containing the human cystic fibrosis transmembrane conductance regulator cDNA.
    Brody SL; Metzger M; Danel C; Rosenfeld MA; Crystal RG
    Hum Gene Ther; 1994 Jul; 5(7):821-36. PubMed ID: 7526901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Aerosol administration of a replication defective recombinant adenovirus expressing normal human cDNA-CFTR in the respiratory tractus in patients with cystic fibrosis].
    Bellon G; Calmard L; Thouvenot D; Levrey H; Jagneaux V; Poitevin F; Malcus C; Accart N; Séné C; Layani MP; Aymard M; Bienvenu J; Courtney M; Döring G; Gilly B; Gilly R; Lamy D; Morel Y; Paulin C; Perraud F; Rodillon L; So S; Touraine F; Schatz C; Pavirani A
    C R Seances Soc Biol Fil; 1996; 190(1):109-42. PubMed ID: 8881273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increasing expression of the normal human CFTR cDNA in cystic fibrosis epithelial cells results in a progressive increase in the level of CFTR protein expression, but a limit on the level of cAMP-stimulated chloride secretion.
    Rosenfeld MA; Rosenfeld SJ; Danel C; Banks TC; Crystal RG
    Hum Gene Ther; 1994 Sep; 5(9):1121-9. PubMed ID: 7530494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo evaluation of the safety of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator cDNA to the lung.
    Yei S; Mittereder N; Wert S; Whitsett JA; Wilmott RW; Trapnell BC
    Hum Gene Ther; 1994 Jun; 5(6):731-44. PubMed ID: 7948135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vector-specific complementation profiles of two independent primary defects in cystic fibrosis airways.
    Zhang Y; Jiang Q; Dudus L; Yankaskas JR; Engelhardt JF
    Hum Gene Ther; 1998 Mar; 9(5):635-48. PubMed ID: 9551612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Airway epithelial CFTR mRNA expression in cystic fibrosis patients after repetitive administration of a recombinant adenovirus.
    Harvey BG; Leopold PL; Hackett NR; Grasso TM; Williams PM; Tucker AL; Kaner RJ; Ferris B; Gonda I; Sweeney TD; Ramalingam R; Kovesdi I; Shak S; Crystal RG
    J Clin Invest; 1999 Nov; 104(9):1245-55. PubMed ID: 10545523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of repetitive adenovirus-mediated transfer of CFTR cDNA to airway epithelia of primates and cotton rats.
    Zabner J; Petersen DM; Puga AP; Graham SM; Couture LA; Keyes LD; Lukason MJ; St George JA; Gregory RJ; Smith AE
    Nat Genet; 1994 Jan; 6(1):75-83. PubMed ID: 7511023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aerosol and lobar administration of a recombinant adenovirus to individuals with cystic fibrosis. I. Methods, safety, and clinical implications.
    Joseph PM; O'Sullivan BP; Lapey A; Dorkin H; Oren J; Balfour R; Perricone MA; Rosenberg M; Wadsworth SC; Smith AE; St George JA; Meeker DP
    Hum Gene Ther; 2001 Jul; 12(11):1369-82. PubMed ID: 11485629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of a cAMP-stimulated chloride secretion in regenerating poorly differentiated airway epithelial cells by adenovirus-mediated CFTR gene transfer.
    Dupuit F; Chinet T; Zahm JM; Pierrot D; Hinnrasky J; Kaplan H; Bonnet N; Puchelle E
    Hum Gene Ther; 1997 Aug; 8(12):1439-50. PubMed ID: 9287144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenovirus 5-fiber 35 chimeric vector mediates efficient apical correction of the cystic fibrosis transmembrane conductance regulator defect in cystic fibrosis primary airway epithelia.
    Granio O; Ashbourne Excoffon KJ; Henning P; Melin P; Norez C; Gonzalez G; Karp PH; Magnusson MK; Habib N; Lindholm L; Becq F; Boulanger P; Zabner J; Hong SS
    Hum Gene Ther; 2010 Mar; 21(3):251-69. PubMed ID: 19788389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo adenovirus-mediated transfer of human CFTR cDNA to rhesus monkey airway epithelium: efficacy, toxicity and safety.
    Bout A; Imler JL; Schultz H; Perricaudet M; Zurcher C; Herbrink P; Valerio D; Pavirani A
    Gene Ther; 1994 Nov; 1(6):385-94. PubMed ID: 7584104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenovirus-mediated generation of cAMP-stimulated Cl- transport in cystic fibrosis airway epithelia in vitro: effect of promoter and administration method.
    Zabner J; Wadsworth SC; Smith AE; Welsh MJ
    Gene Ther; 1996 May; 3(5):458-65. PubMed ID: 9156806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aerosol and lobar administration of a recombinant adenovirus to individuals with cystic fibrosis. II. Transfection efficiency in airway epithelium.
    Perricone MA; Morris JE; Pavelka K; Plog MS; O'Sullivan BP; Joseph PM; Dorkin H; Lapey A; Balfour R; Meeker DP; Smith AE; Wadsworth SC; St George JA
    Hum Gene Ther; 2001 Jul; 12(11):1383-94. PubMed ID: 11485630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correction of cAMP-stimulated fluid secretion in cystic fibrosis airway epithelia: efficiency of adenovirus-mediated gene transfer in vitro.
    Zabner J; Couture LA; Smith AE; Welsh MJ
    Hum Gene Ther; 1994 May; 5(5):585-93. PubMed ID: 7519884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium.
    Rosenfeld MA; Yoshimura K; Trapnell BC; Yoneyama K; Rosenthal ER; Dalemans W; Fukayama M; Bargon J; Stier LE; Stratford-Perricaudet L
    Cell; 1992 Jan; 68(1):143-55. PubMed ID: 1370653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.